News | January 13, 2010

PET/CT More Accurate than Some Routine Oncology Tests

January 13, 2010 - Compared to computed tomography (CT), mammography and other commonly used tests, positron emission tomography-computed tomography (PET/CT) scans of the whole body may more accurately detect cancer in individuals with related neurologic disorders, according to a report posted online today that will appear in the March print issue of Archives of Neurology, one of the JAMA/Archives journals. Andrew McKeon, M.B., MRCPI, and colleagues at Mayo Clinic, Rochester, Minn., found paraneoplastic neurologic disorders occur in some people with cancer, including lung, breast or ovarian cancer, and may develop when cancer-fighting antibodies mistakenly attack cells in the nervous system. The researchers found that "patients with suspected paraneoplastic neurologic disorders, routine noninvasive oncologic evaluations may be unrevealing." The authors noted, "These standard evaluations include physical examination; computed tomography (CT) of the chest, abdomen and pelvis; mammography in women; and testicular ultrasonography and prostate-specific antigen testing in men." Cancers underlying paraneoplastic neurologic disorders are typically small, restricted to one site and are often not detected until autopsy. The researchers studied cases of 56 patients with suspected paraneoplastic neurologic disorders whose standard evaluations (including CT) did not reveal cancer. All of them underwent PET-CT at Mayo Clinic between 2005 and 2008. Prior to undergoing PET/CT exams, the patients underwent a median of three other screening tests; the most common was CT of the chest, abdomen and pelvis. In 39 percent of the patients, PET/CT detected abnormalities suggestive of cancer, of whom 18 percent had cancer diagnoses confirmed by biopsy or another method. Nine of the 10 were early-stage cancers, and detection facilitated early treatment. Cancer remission was reported in seven patients and improvement in neurologic symptoms in five patients after a median (midpoint) of 11 months of follow-up. While the authors noted they recognize the limitations of PET/CT, they said, "We favor this modality for initial oncologic evaluation of patients in whom a paraneoplastic neurologic disorder is strongly suspected. Elimination of whole-body imaging with CT alone before further imaging with PET/CT could reduce radiation exposure and the total financial burden of testing." Reference: Arch Neurol. 2010;67(3)]: doi:10.1001/archneurol.2009.336. For more information: jama-archives.org and http://archneur.ama-assn.org

Related Content

ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging | August 18, 2017
August 18, 2017 — The American Society of Nuclear Cardiology (ASNC) has released a joint expert consensus document wi
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Imaging | August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | Computed Tomography (CT) | August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
The American Lung Association created LUNG FORCE, a national movement to defeat lung cancer
News | Lung Cancer | August 02, 2017
To raise public awareness of lung cancer—the leading cancer killer of men and women—the American Lung Association's...
GE’s DoseWatch is a digital informatics solution that automatically collects, monitors and reports on radiation dose indices for diagnostic imaging exams
News | Radiation Dose Management | July 31, 2017
GE Healthcare announced that it has licensed computed tomography (CT) organ dosimetry technology developed at Duke...
Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
Contrast Media from Bayer, trends in contrast media and developments in contrast media
Feature | Contrast Media | July 28, 2017 | By Dave Fornell
Here are several updates in medical imaging ...
New York Hospital Finds Significant Cost Savings With Toshiba’s Aquilion One CT
News | Computed Tomography (CT) | July 25, 2017
In five years, Kaleida Health’s Stroke Care Center (SCC) at the Gates Vascular Institute in Buffalo, N.Y., has realized...
Samsung Introduces FDA-Cleared BodyTom Elite CT Scanner
Technology | Computed Tomography (CT) | July 24, 2017
Samsung announced U.S. Food and Drug Administration (FDA) approval of the BodyTom Elite, an upgraded version of its...
Overlay Init